Ching Feng Sun
Direttore/Membro del Consiglio presso HUA ENG WIRE & CABLE CO., LTD.
Posizioni attive di Ching Feng Sun
Società | Posizione | Inizio | Fine |
---|---|---|---|
TAH TONG TEXTILE CO., LTD. | Direttore/Membro del Consiglio | 11/06/2015 | - |
Independent Dir/Board Member | 11/06/2015 | - | |
PIXON TECHNOLOGIES CORPORATION | Direttore/Membro del Consiglio | 16/06/2011 | - |
WONDERFUL HI-TECH CO., LTD. | Direttore/Membro del Consiglio | 08/06/2010 | - |
Independent Dir/Board Member | 08/06/2010 | - | |
HUA ENG WIRE & CABLE CO., LTD. | Direttore/Membro del Consiglio | 17/06/2020 | - |
Independent Dir/Board Member | 17/06/2020 | - | |
CHICONY POWER TECHNOLOGY CO., LTD. | Direttore/Membro del Consiglio | 25/08/2021 | - |
Independent Dir/Board Member | 25/08/2021 | - | |
Sai Chia Investment Co. Ltd. | Presidente | 23/09/2011 | - |
Signax Technology Capital, Inc. | Direttore/Membro del Consiglio | - | - |
Saga-Unitek Ventures | Fondatore | 01/01/1998 | - |
Presidente | 01/01/1998 | - | |
Fitek Photonics Corp. | Presidente | - | - |
░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░ ░░░░░ ░░░ ░░░░ | ░░░░░░░░ | - | - |
░░░░ ░░░░ ░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░ | - | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - | |
░░░░ ░░░ ░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░ ░░ ░░░░░░░ ░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░ ░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Storia della carriera di Ching Feng Sun
Precedenti posizioni note di Ching Feng Sun
Società | Posizione | Inizio | Fine |
---|---|---|---|
░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░ ░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - | |
░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formazione di Ching Feng Sun
University of Michigan | Masters Business Admin |
National Taipei University of Technology | Undergraduate Degree |
Wayne State University (Michigan) | Graduate Degree |
Statistiche
Distribuzione geografica
Taiwan | 20 |
Singapore | 4 |
Stati Uniti | 3 |
Posizioni
Director/Board Member | 17 |
Independent Dir/Board Member | 8 |
Chairman | 4 |
Settori
Health Technology | 5 |
Electronic Technology | 5 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 8 |
---|---|
NEWMAX TECHNOLOGY CO., LTD. | Electronic Technology |
TAH TONG TEXTILE CO., LTD. | Process Industries |
DAITOBO CO., LTD. | Finance |
PIXON TECHNOLOGIES CORPORATION | Electronic Technology |
WONDERFUL HI-TECH CO., LTD. | Producer Manufacturing |
ASLAN PHARMACEUTICALS LIMITED | Health Technology |
HUA ENG WIRE & CABLE CO., LTD. | Producer Manufacturing |
CHICONY POWER TECHNOLOGY CO., LTD. | Electronic Technology |
Aziende private | 15 |
---|---|
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
Kuo Lien Venture Capital Management Consulting Co. | |
Sheng Ta Venture Capital Co. Ltd. | |
Hsin Pao Venture Capital Co. Ltd. | |
Kang Chun Venture Capital Co. Ltd. | |
Yang Ching Co. Ltd. | |
Sai Chia Investment Co. Ltd. | |
LumenMax Optoelectronics Co., Ltd.
LumenMax Optoelectronics Co., Ltd. SemiconductorsElectronic Technology LumenMax Optoelectronics Co., Ltd. manufactures light-emitting diode (LED) and LED module. The company's main products are the printed circuit board, plastic leaded chip carrier light emitting device, and module. It focuses on the manufacture of LED packaging components. These devices are used in consumer products, like household appliances, communications and computers. These are also used in light emitting devices, like indoor and outdoor electronic billboards, traffic signals, panel backlight source, and interior lighting. Its business scope includes the manufacture of electronic parts and components, product design industry, trade of telecommunications equipment and electronic materials, as well as international trade. The company was founded on December 26, 2007 and is headquartered in Zhongli, Taiwan. | Electronic Technology |
TWi Pharmaceuticals, Inc.
TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
Taiwan Venture Capital Association | |
Reber Genetics Co., Ltd.
Reber Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Reber Genetics Co., Ltd. engages in the research, development, production, and sale of animal vaccines. Its products include PRRS and PCV2 subunit vaccines. The company was founded on April 18, 2008 and is headquartered in Taipei, Taiwan. | Health Technology |
Fitek Photonics Corp. | |
Saga-Unitek Ventures | |
Signax Technology Capital, Inc. | |
Emerson Electric (South Asia) Pte Ltd. |
- Borsa valori
- Insiders
- Ching Feng Sun
- Esperienza